BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION

Clinical trials for BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION explained in plain language.

Never miss a new study

Get alerted when new BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION trials appear

Sign up with your email to follow new studies for BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New blood test could spot breast cancer early, study aims to prove it

Diagnosis Recruiting now

This study is testing a new blood test designed to detect breast cancer early. Researchers will enroll 300 women—some with breast cancer and some without—to see if specific markers in the blood can accurately identify the disease. The goal is to develop a simple, non-invasive too…

Matched conditions: BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION

Sponsor: Oncoliq US Inc • Aim: Diagnosis

Last updated Mar 25, 2026 14:07 UTC

BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION

Get alerted when new BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION trials appear

New blood test could spot breast cancer early, study aims to prove it